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Background/aim: We aimed to compare the effectivity of percutaneous disc coagulation therapy (PDCT) and navigable ablation
decompression treatment (L-DISQ) in patients who were diagnosed with cervical disc herniation.
Materials and methods: Visual analog scale (VAS) and Neck Pain Index (NPI) scores were recorded initially and at the 1st, 3rd, 6th, and
12th months after the procedures. Patient Satisfaction Scale (PSS) scores were recorded 12 months after the procedures.
Results: Mean VAS scores were 7.55 and 3.1 points in the PDCT group and 7.6 and 3.00 points in the L-DISQ group; mean NPI scores
were 34.2 and 20.75 points in the PDCT group and and 34.1 and 20.4 points in the L-DISQ group initially and at the 12th month. When
compared between months, there was a significant decrease in time-dependent VAS and NPI scores in both PDCT and L-DISQ groups
(P = 0.001). Some complications included esophageal, vascular, and neural injuries; hoarseness; Horner syndrome; infections; dural
puncture; and muscle spasm. The only difference between groups was the rate of cervical spasm within 1 month after the procedure:
75% in the PDCT group and 15% in the L-DISQ group.
Conclusion: The diameter of the canal of the cervical vertebrae is narrower than of the lumbar and thoracic regions; therefore, the
smaller part of the disc may be sufficient to create clinical signs. The response to decompression therapies is faster in the case of
cervical percutaneous procedures that are performed correctly. Proper patient selection and practitioner’s experience are important in
the treatment success.
Key words: Navigable ablation, intradiscal decompression, percutaneous disc coagulation therapy, cervical herniation

1. Introduction
The most common cause of cervical pain and/or
radiculopathy is the mechanical compression of the roots
due to such degenerative spinal pathologies as cervical
disc herniation (CDH) and spondylosis (1). When
compared to the lumbar region, the diameter of the spinal
canal and neural foramens are narrower in the cervical
spine. Accordingly, although smaller in size and less
protrusive, a cervical disc herniation has a higher risk of
developing radicular symptoms than a lumbar herniation
(2). Functionally, cervical vertebrae are more mobile and
have a wider range of motion than the lumbosacral ones.
Therefore, pain and limitation of motion in the cervical
region lead to considerable discomfort (3). The most
common radiculopathic finding is at the C7 nerve root
location, followed by C6, C8, and C5 in descending order
of frequency (4).
The choice of treatment for CDH is still controversial
since the advantages of surgical treatment methods against

nonsurgical ones have not yet been clearly defined (5).
Interest in percutaneous procedures has increased due to
the lesser threat of secondary tissue damage, operability
with local anesthesia, avoidance of the risks associated
with general anesthesia, and earlier discharge. As a result,
interest in minimally invasive percutaneous methods
for the treatment of CDH has increased, in which the
nucleus pulposus is removed mechanically or through the
application of energy (6,7).
Some of the complications are esophageal, vascular, or
neural injuries; hoarseness; Horner syndrome; infections;
leakage of cerebrospinal fluid; neurological damage;
increase in pain; muscle spasm; and retrosternal and
retropharyngeal pain (8–10).
There are some nonsurgical interventions for the
treatment of CDH that usually aim to directly cauterize the
discal parts, making use of various devices that approach
anteriorly to the cervical disc (11,12). There is a need for
comparative studies analyzing the results and long-term
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effects of these methods. There have been no publications
investigating the performance of percutaneous disc
coagulation therapy (PDCT) on the cervical region and
only one study of cervical intradiscal navigable ablation
decompression treatment (L-DISQ). To the best of our
knowledge, this is the first study to evaluate the use of
PDCT in the cervical region. The aim of this study is
to compare the effectivity of percutaneous PDCT and
L-DISQ ablation decompression treatments in patients
diagnosed with CDH.
2. Materials and methods
Approval for the study was obtained from our institutional
ethics committee. Data on patients who underwent
treatment for pain in the posterior neck and in the
superior extremities using L-DISQ and PDCT and/or with
radiculopathy due to a CDH in the Pain Clinic between
2013 and 2017 was evaluated retrospectively.
2.1. Patient selection
From a total number of 105 patients with neck pain who
were diagnosed with CDH by MRI between 2013 and
2017, 48 were treated with percutaneous decompression.
Forty patients who were able to comply with the 12-month
follow-up period were included in the study.
Inclusion criteria were as follows: Patients aged between
18 and 65 years old in the ASA I–II risk groups with with
pain in the posterior neck and superior extremities and/
or radiculopathy due to CDH were included in the study.
All patients had cervical and upper extremity pain in most
cases spreading to the scapular or occipital regions. None
of the patients had only shoulder or neck pain.
Exclusion criteria were as follows: Cervical myelopathy,
cervical bone malformation leading to symptoms, upper
motor neuron lesion findings with a history of cervical
spinal surgery, extruded disc herniation, accompanying
shoulder joint problems, symptom-related psychological
discomfort, hematologic disorders, polyneuropathy, spinal
cord stenosis, segmental instability or spondylolisthesis
at the target level, infections, neoplastic diseases, and
metabolic bone diseases.
The patients’ demographic data, visual analog scale
(VAS) scores, and Neck Pain Index (NPI) scores were
recorded initially and in the 1st, 3rd, 6th, and 12th months
following the procedures. The Patient Satisfaction Scale
(PSS) scores and cervical spasm rates were recorded in the
12th month following the procedures.
2.2. Used devices
The PDCT system (Plasma D30, Jeisys Corporation, Seoul,
South Korea) and L-DISQ (U&I Co. Uijeongbu, Korea)
were used.
2.3. Procedure
The same position and the same C-arm handling
procedures were used in both patient groups. As two

different devices were used, entry cannulas with different
diameters, 1.2 mm and 0.8 mm, were used in the L-DISQ
and PDCT procedures, respectively.
In order to reduce the risk of infection and for
sedation, 1 g of cefazolin and 2 mg of midazolam were
injected intravenously (IV) prior the procedures. Intense
sedation was avoided to allow full monitoring throughout
the procedure. Patients were calm and able to speak to
the practitioner when necessary. Blood pressure, heart
rate, electrocardiogram, and oxygen saturation were
monitored. While in a supine position, a thin roll was
placed under the shoulders of the patient to allow a
slight neck extension, and the shoulders were stabilized
to allow better visualization of the lower cervical discs if
needed. The neck was prepared and covered with sterile
surgical cloths. First of all, all patients were injected with
a local anesthetic of 2 mL of prilocaine into the skin and
subcutaneous tissues. Deep injection was avoided during
subcutaneous injection of the local anesthetic. This helped
us to prevent development of side effects related to the
local anesthetic agent such as Horner syndrome due to the
proximity to the cervical sympathetic chain, bradycardia
due to the effect on the carotid glomus, and bitonal sound
or hoarseness due to the effect on inferior laryngeal nerve.
An additional 0.5 µg/kg of fentanyl was administered
intravenously in the case of pain until the disc was reached.
The port cannula was placed through the midline into
the right side via an anterolateral approach. Since the
esophagus is located on the left of the midline, a right-sided
approach seems relatively safer, especially at lower cervical
levels. Tight pressure was applied to the space between the
trachea and the medial border of the sternocleidomastoid
muscle in order to remove the trachea from the midline
in a controlled manner. Bleeding/coagulation tests and
anticoagulant drug use were questioned in all patients
before the procedure. The carotid artery was sensed by
the middle and index fingers to determine the entry
point while preventing possible major vascular injury
and hematoma. As the diameter of the cannula is small,
tampon pressure was planned in case of hematoma. A
possible headache due to dural injury was planned to be
treated by daily abundant fluid intake, additional caffeinecontaining painkiller agent, IV hydration, and epidural
blood patch in the event that the headache did not cease
after 1 week of treatment.
The cannula was moved obliquely into the
intervertebral disc area 3–4 cm away from the midline at
the index level. The C-arm was placed to obtain a lateral
view of the surgical field, and then the cannula and trunk
were advanced into the disc under fluoroscopic guidance.
If both the anteroposterior and lateral views were located
in the target area, we defined the needle position as “right”,
and otherwise as “wrong”. The tip was retracted and
retested in the event of such complaints as electric shock-
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like pain or muscle contractions. The pain resulting from
a short test of electrical stimulation can prevent possible
neural tissue damage. For both methods, the total duration
of ablation after test stimulation was 100–150 s.
All patients were prescribed antibiotics to use for 7–10
days and to take an antiinflammatory drug or paracetamol
in the case of pain, along with a hard collar to be worn for 2
weeks during the day. Patients were informed not to drive
for at least 72 h.
No patient required additional invasive pain
intervention after the procedure.
2.4. Statistical analysis
The data analyses were carried out using SPSS 15 for
Windows. Descriptive statistics were expressed as mean ±
standard deviation for variables with normal distribution,
median (min–max) for variables with abnormal
distribution, and number of cases and percentage (%) for
nominal variables. Within the groups, the significance
of the difference in median values and in the median
values between times was assessed with a Friedman test.
If present, multiple intertime comparisons of differences
were evaluated using appropriate post hoc tests. Between
the groups, the significance of the difference in terms of
average values was evaluated by two related sample tests,
and in terms of median values by a Wilcoxon test.

P < 0.05 was considered to be statistically significant,
and a recovery rate of over 50% was considered successful.
3. Results
Forty patients were included in the study, of which 47.5%
were female and 52.5% were male, with a mean age of 53
years. Lesions were predominantly at the C4–C5 and C5–
C6 distances, as summarized in Table 1.
The time-dependent VAS scores were found to be
statistically significant for each treatment method (P =
0.001), as presented in Table 2. In a comparison of the
PDCT and L-DISQ groups, the difference between the VAS
scores in the 0th, 3rd, 6th, and 12th months was statistically
insignificant, while the difference between the VAS scores
in the 1st month was statistically significant (P = 0.033). In
the PDCT group, the time-dependent VAS scores between
the 1st and 3rd months were significant at P = 0.039 and
between the 3rd and 12th months were significant at P
= 0.012. In the L-DISQ group, the time-dependent VAS
scores between the 0th and 1st, 0th and 3rd, 0th and 6th,
and 0th and 12th months were P = 0.0019, and between
the 3rd and 12th and 6th and 12th months were P = 0.008,
and thus statistically significant (Table 2).
The time-dependent NPI scores were found to be
statistically significant for each treatment (P = 0.001).

Table 1. Demographic data.
PDCT

n

%

L-DISQ, n

%

Male

9

42.9

12

57.1

Female

11

57.9

8

42.1

C3–C4, C4–C5

5

25.0

3

15.0

C4–C5, C5–C6

7

35.0

7

35.0

C5–C6

3

15.0

4

20.0

C5–C6, C6–C7

3

15.0

3

15.0

C4–C5

2

10.0

3

15.0

Yes

13

65

4

20

No

7

35

16

80

Very good

1

5.0

1

5.0

Good

14

70.0

16

80.0

Moderate

5

25.0

3

15.0

Sex

Level

Cervical spasm

PSS

PSS: Patient Satisfaction Scale; PDCT: plasma laser disc coagulation.
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Table 2. VAS score data.
Comparison of VAS scores according to method, PDCT vs. L-DISQ
Time

VAS PDCT

VAS L-DISQ

P1

0th month

7.55 ± 0.61

7.6 ± 0.68

0.88

1st month

3.55 ± 0.51

3.15 ± 0.59

0.033*

3rd month

3.6 ± 0.6

3.5 ± 0.51

0.643

6th month

3.3 ± 0.57

3.35 ± 0.59

0.768

12th month

3.1 ± 0.55

3 ± 0.56

0.568

Comparison of time-dependent VAS scores
Time

VAS PDCT / P2

VAS L-DISQ / P2

0–1 months

0.001*

0.001*

0–3 months

0.001*

0.001*

0–6 months

0.001*

0.001*

0–12 months

0.001*

0.001*

1–3 months

0.763

0.052

1–6 months

0.225

0.157

1–12 months

0.039*

0.317

3–6 months

0.083

0.366

3–12 months

0.012*

0.008*

6–12 months

0.206

0.008*

VAS: Visual analog scale. *Significant for P < 0.05, P1: Wilcoxon Mann–Whitney U; P2:
Friedman test.

Time-dependent NPI scores are shown in Table 3. In
a comparison of the PDCT and L-DISQ groups, the
differences between the NPI scores in the 0th, 1st, 3rd,
6th, and 12th months were statistically insignificant. In
the PDCT group, the differences in the time-dependent
NPI scores between month 0 and the other months
were statistically significant at P = 0.001. The differences
between the 1st and 3rd, 1st and 6th, and 1st and 12th
months were also statistically significant at P = 0.001,
0.011, and 0.006. In the L-DISQ group, the time-dependent
NPI scores between month 0 and all the other months,
and also between the 1st and 6th months, were statistically
significant at P = 0.001, while the scores between the 1st
and 3rd months were also statistically significant at P =
0.009 (Table 3).
Among the PDCT patients, one patient rated the PSS
as very good, while 14 patients and 5 patients rated it as
good and moderate, respectively. Among the L-DISQ
patients, 1, 16, and 3 rated the PSS as very good, good,
and moderate. Of the 40 patients included, 2, 30, and 8
rated the PSS at the 12th month as very good, good,
and moderate, respectively. Overall, 80% of the patients
evaluated the procedure as very good or good according
to the PSS (Table 1).

4. Discussion
In recent years, less invasive procedures have been
developed for the treatment of patients with CDH,
including those that use mechanical, chemical, and
thermal methods to compress the discs (13,14).
Although authors have previously addressed lumbar
interventions in the literature, the present study discusses
cervical interventions.
During the follow-up year, a statistically significant
reduction was noted in both VAS and NPI index scores in
the PDCT and L-DISQ groups. The neck pain felt during
the procedure and the risk of postoperative muscular
spasm was reduced. Cervical spasm developed in 13 and
did not develop in 7 of the PDCT patients, and among
the L-DISQ patients, cervical spasm developed in 4 and
did not develop in 16. The patients who experienced
cervical spasms benefited from such short-term palliative
treatments as supportive physical therapy, hot compress,
and analgesics (Table 1).
PDCT works by using a laser source called a plasma
light, and produced plasma rays condense at the end of
the dome-shaped probe and do not move forward. A fire
sphere with a diameter of 4 mm is created around the
coagulation area and all energy is concentrated at the end of
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Table 3. NPI score data.
NPI scores according to method, PDCT vs. L-DISQ
Time

NPI PDCT

NPI L-DISQ

P1

0 month

34.2 ± 1.64

34.1 ± 1.48

0.89

1st month

22.85 ± 2.25

21.6 ± 1.93

0.095

3rd month

20.7 ± 1.3

20.4 ± 1.05

0.238

6th month

21.1 ± 1.37

20.65 ± 1.09

0.427

12th month

20.75 ± 1.37

20.4 ± 0.1

0.273

Comparison of time-dependent NPI scores
Time

NPI PDCT / P

NPI L-DISQ / P

0–1 months

0.001*

0.001*

0–3 months

0.001*

0.001*

0–6 months

0.001*

0.001*

0–12 months

0.001*

0.001*

1–3 months

0.001*

0.009*

1–6 months

0.011*

0.001*

1–12 months

0.006*

0.077

3–6 months

0.269

0.349

3–12 months

1.000

1.000

6–12 months

0.287

0.479

NPI: Neck Pain Index. *Significant for P < 0.05, P1: Wilcoxon Mann–Whitney U; P2:
Friedman test.

the fiber. The PDCT system is a type of therapeutic system
for disc coagulation, evaporation, and decompression with
plasma. Most lasers use a power of 900 J in a pulsatile
mode at cervical distances (15). The area within 4 mm
around the tip on the fiber is lower than 40 °C for safety.
This is why adjusting and healthy tissues are protected
from thermal elevations. The diameter of the plasma fiber
optic is 0.4 mm. The basic principle is to create 3 lesions in
the intradiscal region. During the process, the evaporated
disc is checked for output by opening a three-way valve
(16). The total surgical procedure takes 15 min.
Bellini et al. reported preliminary results of 19 patients
with lumbar or cervical disc herniation treated with PDCT,
defining the process according to quarterly evaluated VAS
scores. No serious complications were reported, aside
from mild muscular spasm and stomach complaints in
10 patients. Despite the fact that PDCT uses a modified
plasma laser technology, we believe that the cervical
muscular spasms were related directly to the high power
effect of the applied energy (15,16).
L-DISQ is a device that approaches the herniated disc
sensitively along the intradiscal pathway and vaporizes
the herniated nucleus using plasma particles and bipolar
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radiofrequency plasma for decompression. This device has
been replaced with a valid form called L-DISQ-C to enter
the cervical intervertebral space (17).
The navigable electrode end of the L-DISQ is twisted
by turning the control wheel and can penetrate completely
into the discal hernia. This feature provides direct access
to the herniated part of the disc to be ablated and reduces
the amount of ablated discal tissue and fibrous damage to
the outer ring (18).
Since the distance between two electrodes at the
end of L-DISQ is 0.2 mm, a nerve root farther from the
electrode tip than 0.2 mm is theoretically protected from
electrical damage. During the procedure, electrical current
passes through the other electrode instead of the nerve
root (17). Additionally, the thin outer membrane ring
is a good barrier for electrical current and theoretically
reduces nerve damage due to bipolar electrical coupling
(13). During controllable ablation, the highest recorded
temperature is between 40 and 60 °C and the temperature
decreases rapidly with distance (19). This is why adjusting
and healthy tissues are protected from thermal elevations.
Temperatures do not rise inside or on the surface of the
disc, but do rise significantly around the probe tip. As a
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result, nerves and surrounding tissues are protected from
the risk of thermal damage as long as the probe tip is within
the disc (20). The total surgical procedure takes 15 min.
Lim et al., following interventions with L-DISQ
in patients with extruded and protruded cervical disc
herniation, came to conclusions that paralleled those of
the present study (21). In the study by Kim (22), L-DISQ
had technical properties that facilitated its use in extruded
cervical disc hernias.
Unlike in our study, previous studies using L-DISQ
in the treatment of cervical disc herniation included
extruded patients, but we only treated patients with
protruded discs. We believe that it is more suitable to
access to the target tissue in protruding disc hernias with
higher rates of success. For the placement of the electrode
by navigation within the herniated part, the experience of
the practitioner and proper patient selection are important
factors affecting success. Precise access to the target is
crucial for success. In the present study, we observed no
indications that the electrode had been falsely placed.
In some of the patients in the present study, intradiscal
treatment was applied at multiple levels, while all
interventions in other studies were made at a single level.
Although PDCT is used to reduce the problems
associated with other laser applications, its probe cannot
be seen in the disc through fluoroscopy, which can be
considered a disadvantage (Figure). Since the entrance
cannula of the PDCT is thinner than the L-DISQ cannula,
intradiscal access is easier, despite the potential for bone
surface problems. This feature provides significant benefit
to the user. L-DISQ can be monitored under fluoroscopy,
including its tip, which is an advantage for L-DISQ users.
In our study, we did not perform MRI routinely for
follow-up after the procedure. The pain and functional
status was determined by clinical anamnesis and physical
examination. Bonaldi et al. (8) reported that clinical
improvement was not always accompanied by MRI
findings. Schellhas et al. (7) reported that pain did not
always correlate with radiological findings. Similarly,
Arana et al. (18) did not observe a significant correlation
between MRI findings and pain and various clinical signs.
In conclusion, L-DISQ provided better pain control
than PDCT in the early period while both methods were
found to have similar effectivity in the long term. In the
PDCT group, the higher VAS score values in the early
period were thought to be associated with paracervical

Figure. Although PDCT is used to reduce the problems
associated with other laser applications, its probe cannot be seen
in the disc through fluoroscopy.

muscle spasms. The outcome of neither treatment method
was superior to the other in terms of the outcomes of
the two groups in treatment follow-up. The decreases in
the VAS and NPI scores of the patients were statistically
significantly. We believe that PDCT and L-DISQ can be
considered safe and efficient procedures in patients with
CDH.
Although NPI evaluates the functional improvements
of CDH patients and includes some questions judging
parameters such as social life, daily functionality, and
sleep quality, some additional indexes and questionnaires
supporting these parameters can be evaluated in further
studies including larger patient populations.
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